Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FN1SM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,011
Award facts
- Contract value 100% obligated
- $10,011.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of XOLAIR 150 MG/1.2 ML Powder VLS, a pharmaceutical product used in the treatment of moderate-to-severe allergic asthma. This competitively awarded, firm fixed-price delivery order, with no set-aside designation, carries a ceiling value of $10,011.00 and is scheduled for completion by May 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which serves as the place of performance—is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in supplying comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products, medications, vaccines, and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support is concurrently pursuing a strategic initiative to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue as a key supplier within the federal military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FN1SM?
SPE2DB25FN1SM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FN1SM worth?
The government has obligated $10,011 on SPE2DB25FN1SM.
Is contract SPE2DB25FN1SM an order under another contract?
Yes. SPE2DB25FN1SM is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN1SM competed?
The extent of competition for SPE2DB25FN1SM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award